3-chloro-L-tyrosine has been researched along with Chronic Kidney Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshinnia, F; Byun, J; Gadegbeku, CA; Kretzler, M; Magnone, MC; Pennathur, S; Valastro, B; Whatling, C; Zeng, L | 1 |
1 other study(ies) available for 3-chloro-L-tyrosine and Chronic Kidney Diseases
| Article | Year |
|---|---|
Myeloperoxidase Levels and Its Product 3-Chlorotyrosine Predict Chronic Kidney Disease Severity and Associated Coronary Artery Disease.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Coronary Artery Disease; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged; Oxidative Stress; Peroxidase; Renal Insufficiency, Chronic; Risk Factors; Severity of Illness Index; Tyrosine; Young Adult | 2017 |